Epidemiology of Ischemic Stroke

Epidemiology of Ischemic Stroke

registre avc
Since 1985, the Dijon Stroke Registry has continuously collected all cases of stroke, including cerebral infarction, intracerebral hemorrhage and meningeal hemorrhage, as well as transient ischemic attacks (TIA), occurring in residents of Dijon. It is the oldest ongoing population registry in the world. It collects data from multiple sources, thus requiring cooperation between different healthcare professionals in the hospital and private sector. The Dijon Stroke Registry is accredited by the ‘Comité d’Evaluation des Registres’ and is supported by the INSERM and Public Health in France.
Every year, around 400 patients are included in the Dijon Stroke Registry.

 

 

 

The Dijon Stroke Registry has a number of objectives:

  • Provide epidemiological data (rates of incidence, mortality, handicap and recurrences) and to draw comparisons with other countries to understand the differences observed.
  • Evaluate the evolution over time of these data so as to analyze the impact of demographic changes in the population as well as the impact of prevention measures , curative treatments and medical practices.
  • Describe outcomes in patients after a stroke in terms of functional repercussions (handicap and dependence), psychiatric and cognitive repercussions , and the consequences on social aspects and quality of life.
  • Identify new risk factors and triggering factors of stroke and evaluate the impact of implementing preventive measures on the evolution of stroke incidence.
  • Identify factors associated with a poor vital, functional, cognitive and general prognosis,  and model prognostic scores so as to identify patients with a risk of a poor outcome early, in order to implement specific therapeutic measures.
  • Develop suitable tools to assess the prognosis in stroke patients with the aim to promote their use in routine practice to follow patients.
  • Develop new technologies to improve the follow-up of patients and to strengthen prevention.
  • Use observational data to raise pathophysiological hypotheses and develop transversal research starting from experimental studies carried out at EA 7460.